SLC7A5 and cancer: An analysis of LAT1 expression was conducted between the primary site and a concordant pulmonary metastatic site in 93 cancer patients, including those with colon cancers, breast cancers, head and neck cancers, genital cancers, and soft-tissue sarcomas.